Log in
RegisterBioequivalence of mirabegron 50 mg extended release Tablet [Design Issues]
Dear Ibrahim,
I know it is very late response but here you can find the literature mentioning the high variability of mirabegron (approximately 33% to 45% for Cmax and 19% to 31% for AUC) AUS PAR.
Hope it may help other forum members.
Regards.
❝ Knowing that I couldn't find an accurate data for intrasubject variability of Mirabegnon.
I know it is very late response but here you can find the literature mentioning the high variability of mirabegron (approximately 33% to 45% for Cmax and 19% to 31% for AUC) AUS PAR.
Hope it may help other forum members.
Regards.
Complete thread:
- Bioequivalence of mirabegron 50 mg extended release Tablet Ibrahim Komeil 2021-02-20 11:36
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- Replicate designs based on information of 2×2×2 design Helmut 2021-02-20 14:50
- Replicate designs based on information of 2×2×2 design Ibrahim Komeil 2021-02-20 18:34
- Assumption of authority? Helmut 2021-02-20 20:50
- Replicate designs based on information of 2×2×2 design Ibrahim Komeil 2021-02-20 18:34
- Bioequivalence of mirabegron 50 mg extended release Tablet jishnu 2022-08-04 09:09
- Bioequivalence of mirabegron 50 mg extended release Tabletqualityassurance 2022-08-04 15:47
- Replicate designs based on information of 2×2×2 design Helmut 2021-02-20 14:50
Ing. Helmut Schütz